233 related articles for article (PubMed ID: 9599733)
1. Daytime functional bladder capacity as a predictor of response to desmopressin in monosymptomatic nocturnal enuresis.
Eller DA; Austin PF; Tanguay S; Homsy YL
Eur Urol; 1998; 33 Suppl 3():25-9. PubMed ID: 9599733
[TBL] [Abstract][Full Text] [Related]
2. Spot urine osmolality, age and bladder capacity as predictors of response to desmopressin in nocturnal enuresis.
Eller DA; Homsy YL; Austin PF; Tanguay S; Cantor A
Scand J Urol Nephrol Suppl; 1997; 183():41-5. PubMed ID: 9165605
[TBL] [Abstract][Full Text] [Related]
3. Functional bladder capacity as predictor of response to desmopressin and retention control training in monosymptomatic nocturnal enuresis.
Hamano S; Yamanishi T; Igarashi T; Ito H; Murakami S
Eur Urol; 2000 Jun; 37(6):718-22. PubMed ID: 10828674
[TBL] [Abstract][Full Text] [Related]
4. The efficacy of DDAVP is related to the circadian rhythm of urine output in patients with persisting nocturnal enuresis.
Hunsballe JM; Hansen TK; Rittig S; Pedersen EB; Djurhuus JC
Clin Endocrinol (Oxf); 1998 Dec; 49(6):793-801. PubMed ID: 10209568
[TBL] [Abstract][Full Text] [Related]
5. Characteristics of a tertiary center enuresis population, with special emphasis on the relation among nocturnal diuresis, functional bladder capacity and desmopressin response.
Dehoorne JL; Walle CV; Vansintjan P; Raes AM; De Guchtenaere AR; Van Laecke E; Hoebeke P; Vande Walle JG
J Urol; 2007 Mar; 177(3):1130-7. PubMed ID: 17296432
[TBL] [Abstract][Full Text] [Related]
6. Nocturnal enuresis and daytime wetting: a multicentric trial with oxybutynin and desmopressin.
Caione P; Arena F; Biraghi M; Cigna RM; Chendi D; Chiozza ML; De Lisa A; De Grazia E; Fano M; Formica P; Garofalo S; Gramenzi R; von Heland M; Lanza P; Lanza T; Maffei S; Manieri C; Merlini E; Miano L; Nappo S; Pagliarulo A; Paolini Paoletti F; Pau AC; Porru D; Artibani W
Eur Urol; 1997; 31(4):459-63. PubMed ID: 9187908
[TBL] [Abstract][Full Text] [Related]
7. Long-term home studies of water balance in patients with nocturnal enuresis.
Rittig S; Schaumburg H; Schmidt F; Hunsballe JM; Hansen AF; Kirk J; Vestergaard P; Djurhuus JC
Scand J Urol Nephrol Suppl; 1997; 183():25-6; discussion 26-7. PubMed ID: 9165600
[TBL] [Abstract][Full Text] [Related]
8. The influence of small functional bladder capacity and other predictors on the response to desmopressin in the management of monosymptomatic nocturnal enuresis.
Rushton HG; Belman AB; Zaontz MR; Skoog SJ; Sihelnik S
J Urol; 1996 Aug; 156(2 Pt 2):651-5. PubMed ID: 8683752
[TBL] [Abstract][Full Text] [Related]
9. Desmopressin for nocturnal enuresis: urinary osmolality and response.
Folwell AJ; Macdiarmid SA; Crowder HJ; Lord AD; Arnold EP
Br J Urol; 1997 Sep; 80(3):480-4. PubMed ID: 9313673
[TBL] [Abstract][Full Text] [Related]
10. Monosymptomatic primary enuresis: differences between patients responding or not responding to oral desmopressin.
Medel R; Dieguez S; Brindo M; Ayuso S; Canepa C; Ruarte A; Podesta ML
Br J Urol; 1998 May; 81 Suppl 3():46-9. PubMed ID: 9634019
[TBL] [Abstract][Full Text] [Related]
11. The evaluation of desmopressin in treatment of adolescent nocturnal enuresis.
Derman O; Kanbur NO; Kinik E
Int J Adolesc Med Health; 2004; 16(4):377-85. PubMed ID: 15712975
[TBL] [Abstract][Full Text] [Related]
12. Alarm treatment: influence on functional bladder capacity.
Hansen AF; Jørgensen TM
Scand J Urol Nephrol Suppl; 1997; 183():59-60. PubMed ID: 9165610
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of oral desmopressin in the treatment of primary nocturnal enuresis in Asian children.
Yap HK; Chao SM; Tan AY; Murugasu B; Ong EK; Low EH
J Paediatr Child Health; 1998 Apr; 34(2):151-3. PubMed ID: 9588639
[TBL] [Abstract][Full Text] [Related]
14. Desmopressin in nocturnal enuresis.
Aladjem M; Wohl R; Boichis H; Orda S; Lotan D; Freedman S
Arch Dis Child; 1982 Feb; 57(2):137-40. PubMed ID: 7039520
[TBL] [Abstract][Full Text] [Related]
15. Pretreatment morning urine osmolality and oral desmopressin lyophilisate treatment outcome in patients with primary monosymptomatic enuresis.
Abdovic S; Cuk M; Hizar I; Milosevic M; Jerkovic A; Saraga M
Int Urol Nephrol; 2021 Aug; 53(8):1529-1534. PubMed ID: 33774753
[TBL] [Abstract][Full Text] [Related]
16. The relationship between desmopressin treatment and voiding pattern in children.
Hvistendahl GM; Rawashdeh YF; Kamperis K; Hansen MN; Rittig S; Djurhuus JC
BJU Int; 2002 Jun; 89(9):917-22. PubMed ID: 12010240
[TBL] [Abstract][Full Text] [Related]
17. Intermittent oral desmopressin therapy for monosymptomatic primary nocturnal enuresis.
Akbal C; Ekici S; Erkan I; Tekgül S
J Urol; 2004 Jun; 171(6 Pt 2):2603-6. PubMed ID: 15118429
[TBL] [Abstract][Full Text] [Related]
18. Ultrasound bladder measurements in patients with primary nocturnal enuresis: a urodynamic and treatment outcome correlation.
Yeung CK; Sreedhar B; Leung VT; Metreweli C
J Urol; 2004 Jun; 171(6 Pt 2):2589-94. PubMed ID: 15118426
[TBL] [Abstract][Full Text] [Related]
19. Primary nocturnal enuresis and desmopressin treatment: do psychosocial factors affect outcome?
Dittmann RW; Wolter S
Eur Child Adolesc Psychiatry; 1996 Jun; 5(2):101-9. PubMed ID: 8814416
[TBL] [Abstract][Full Text] [Related]
20. Micturition habits and bladder capacity in normal children and in patients with desmopressin-resistant enuresis.
Kirk J; Rasmussen PV; Rittig S; Djurhuus JC
Scand J Urol Nephrol Suppl; 1995; 173():49-50. PubMed ID: 8719566
[No Abstract] [Full Text] [Related]
[Next] [New Search]
